Risk perception of the antimicrobial resistance by infection control specialists in Europe : a case-vignette study
BACKGROUND: Using case-vignettes, we assessed the perception of European infection control (IC) specialists regarding the individual and collective risk associated with antimicrobial resistance (AMR) among inpatients.
METHODS: In this study, sixteen case-vignettes were developed to simulate hospitalised patient scenarios in the field of AMR and IC. A total of 245 IC specialists working in different hospitals from 15 European countries were contacted, among which 149 agreed to participate in the study. Using an online database, each participant scored five randomly-assigned case-vignettes, regarding the perceived risk associated with six different multidrug resistant organisms (MDRO). The intra-class correlation coefficient (ICC), varying from 0 (poor) to 1 (perfect), was used to assess the agreement for the risk on a 7-point Likert scale. High risk and low/neutral risk scorers were compared regarding their national, organisational and individual characteristics.
RESULTS: Between January and May 2017, 149 participants scored 655 case-vignettes. The perceptions of the individual (clinical outcome) and collective (spread) risks were consistently lower than other MDRO for extended spectrum beta-lactamase producing Enterobacteriaceae cases and higher for carbapenemase producing Enterobacteriaceae (CPE) cases. Regarding CPE cases, answers were influenced more by the resistance pattern (93%) than for other MDRO. The risk associated with vancomycin resistant Enterococci cases was considered higher for the collective impact than for the individual outcome (63% vs 40%). The intra-country agreement regarding the individual risk was globally poor varying from 0.00 (ICC: 0-0.25) to 0.51 (0.18-0.85). The overall agreement across countries was poor at 0.20 (0.07-0.33). IC specialists working in hospitals preserved from MDROs perceived a higher individual (local, p = 0.01; national, p < 0.01) and collective risk (local and national p < 0.01) than those frequently exposed to bacteraemia. Conversely, IC specialists working in hospitals with a high MDRO clinical burden had a decreased risk perception.
CONCLUSIONS: The perception of the risk associated with AMR varied greatly across IC specialists and countries, relying on contextual factors including the epidemiology. IC specialists working in high prevalence areas may underestimate both the individual and collective risks, and might further negatively promote the MDRO spread. These finding highlight the need to shape local and national control strategies according to risk perceptions and contextual factors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Antimicrobial resistance and infection control - 9(2020), 1 vom: 14. Feb., Seite 33 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Birgand, Gabriel [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 29.12.2020 Date Revised 29.12.2020 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13756-020-0695-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306539152 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306539152 | ||
| 003 | DE-627 | ||
| 005 | 20231225123604.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13756-020-0695-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1021.xml |
| 035 | |a (DE-627)NLM306539152 | ||
| 035 | |a (NLM)32059746 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Birgand, Gabriel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk perception of the antimicrobial resistance by infection control specialists in Europe |b a case-vignette study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.12.2020 | ||
| 500 | |a Date Revised 29.12.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Using case-vignettes, we assessed the perception of European infection control (IC) specialists regarding the individual and collective risk associated with antimicrobial resistance (AMR) among inpatients | ||
| 520 | |a METHODS: In this study, sixteen case-vignettes were developed to simulate hospitalised patient scenarios in the field of AMR and IC. A total of 245 IC specialists working in different hospitals from 15 European countries were contacted, among which 149 agreed to participate in the study. Using an online database, each participant scored five randomly-assigned case-vignettes, regarding the perceived risk associated with six different multidrug resistant organisms (MDRO). The intra-class correlation coefficient (ICC), varying from 0 (poor) to 1 (perfect), was used to assess the agreement for the risk on a 7-point Likert scale. High risk and low/neutral risk scorers were compared regarding their national, organisational and individual characteristics | ||
| 520 | |a RESULTS: Between January and May 2017, 149 participants scored 655 case-vignettes. The perceptions of the individual (clinical outcome) and collective (spread) risks were consistently lower than other MDRO for extended spectrum beta-lactamase producing Enterobacteriaceae cases and higher for carbapenemase producing Enterobacteriaceae (CPE) cases. Regarding CPE cases, answers were influenced more by the resistance pattern (93%) than for other MDRO. The risk associated with vancomycin resistant Enterococci cases was considered higher for the collective impact than for the individual outcome (63% vs 40%). The intra-country agreement regarding the individual risk was globally poor varying from 0.00 (ICC: 0-0.25) to 0.51 (0.18-0.85). The overall agreement across countries was poor at 0.20 (0.07-0.33). IC specialists working in hospitals preserved from MDROs perceived a higher individual (local, p = 0.01; national, p < 0.01) and collective risk (local and national p < 0.01) than those frequently exposed to bacteraemia. Conversely, IC specialists working in hospitals with a high MDRO clinical burden had a decreased risk perception | ||
| 520 | |a CONCLUSIONS: The perception of the risk associated with AMR varied greatly across IC specialists and countries, relying on contextual factors including the epidemiology. IC specialists working in high prevalence areas may underestimate both the individual and collective risks, and might further negatively promote the MDRO spread. These finding highlight the need to shape local and national control strategies according to risk perceptions and contextual factors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Antimicrobial resistance | |
| 650 | 4 | |a Carbapenemase-producing Acinetobacter baumannii | |
| 650 | 4 | |a Carbapenemase-producing Enterobacteriaceae | |
| 650 | 4 | |a Carbapenemase-producing Pseudomonas aeruginosa | |
| 650 | 4 | |a Europe | |
| 650 | 4 | |a Infection prevention and control | |
| 650 | 4 | |a Meticillin-resistant Staphylococcus aureus | |
| 650 | 4 | |a Risk perception | |
| 650 | 4 | |a Vancomycin-resistant Enterococci | |
| 700 | 1 | |a Mutters, Nico T |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Raheelah |e verfasserin |4 aut | |
| 700 | 1 | |a Tacconelli, Evelina |e verfasserin |4 aut | |
| 700 | 1 | |a Lucet, Jean-Christophe |e verfasserin |4 aut | |
| 700 | 1 | |a Holmes, Alison |e verfasserin |4 aut | |
| 700 | 0 | |a Percept-R Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Asensio, Angel |e investigator |4 oth | |
| 700 | 1 | |a Buke, Cagri |e investigator |4 oth | |
| 700 | 1 | |a Markovic-Denic, Ljiljana |e investigator |4 oth | |
| 700 | 1 | |a da Graca Domingues Rocha, Maria |e investigator |4 oth | |
| 700 | 1 | |a Kluytmans, Jan |e investigator |4 oth | |
| 700 | 1 | |a Lyytikainen, Outi |e investigator |4 oth | |
| 700 | 1 | |a Otter, Jonathan A |e investigator |4 oth | |
| 700 | 1 | |a Presterl, Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Salmanov, Aidyn |e investigator |4 oth | |
| 700 | 1 | |a Schaffer, Kirsten |e investigator |4 oth | |
| 700 | 1 | |a Rodriguez Bano, Jesús |e investigator |4 oth | |
| 700 | 1 | |a Schechner, Vered |e investigator |4 oth | |
| 700 | 1 | |a Szilagyi, Emese |e investigator |4 oth | |
| 700 | 1 | |a Tsakris, Athanassios |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Antimicrobial resistance and infection control |d 2012 |g 9(2020), 1 vom: 14. Feb., Seite 33 |w (DE-627)NLM220841640 |x 2047-2994 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2020 |g number:1 |g day:14 |g month:02 |g pages:33 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13756-020-0695-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2020 |e 1 |b 14 |c 02 |h 33 | ||